期刊
CANCER AND METASTASIS REVIEWS
卷 37, 期 4, 页码 599-614出版社
SPRINGER
DOI: 10.1007/s10555-018-9761-x
关键词
Male breast cancer; BRCA; Epidemiology; Surgery; Endocrine therapy; Chemotherapy; Radiation therapy
类别
Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA. Because of its rarity, most major breast cancer trials have included only female patients. This has resulted in limited prospective data to guide the clinical management of men with breast cancer. As a result, treatment decisions are typically extrapolated from data generated in female patients. This approach may be suboptimal, particularly considering the differing hormonal milieus between men and women with respect to both breast cancer development and treatment. Herein, we summarize current knowledge of the biology and clinicopathology of male breast cancer and review current approaches to locoregional and systemic management of this rare disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据